These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15967786)

  • 61. The CD19/CD21 signal transduction complex of B lymphocytes.
    Tedder TF; Zhou LJ; Engel P
    Immunol Today; 1994 Sep; 15(9):437-42. PubMed ID: 7524521
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome.
    Henriquez NV; Rijkers GT; Zegers BJ
    J Immunol; 1994 Jul; 153(1):395-9. PubMed ID: 7515927
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD19 can regulate B lymphocyte signal transduction independent of complement activation.
    Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Tedder TF
    J Immunol; 2001 Sep; 167(6):3190-200. PubMed ID: 11544305
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enteroantigen (eAg)-binding B lymphocytes in the mouse - phenotype, distribution, function and eAg-specific antibody secretion.
    Venning FA; Trempenau ML; Schmidt E; Claesson MH
    APMIS; 2014 Jul; 122(7):616-27. PubMed ID: 24303790
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes.
    Fearon DT
    Curr Opin Immunol; 1993 Jun; 5(3):341-8. PubMed ID: 7688513
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.
    Zhou ZH; Notkins AL
    Clin Exp Immunol; 2004 Jul; 137(1):88-100. PubMed ID: 15196248
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CD19 and CD32b differentially regulate human B cell responsiveness.
    Karnell JL; Dimasi N; Karnell FG; Fleming R; Kuta E; Wilson M; Wu H; Gao C; Herbst R; Ettinger R
    J Immunol; 2014 Feb; 192(4):1480-90. PubMed ID: 24442430
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes.
    Inaoki M; Sato S; Weintraub BC; Goodnow CC; Tedder TF
    J Exp Med; 1997 Dec; 186(11):1923-31. PubMed ID: 9382890
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Through an ITIM-independent mechanism the FcγRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19.
    Xu L; Li G; Wang J; Fan Y; Wan Z; Zhang S; Shaheen S; Li J; Wang L; Yue C; Zhao Y; Wang F; Brzostowski J; Chen YH; Zheng W; Liu W
    J Immunol; 2014 Jun; 192(11):5179-91. PubMed ID: 24790152
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thiol-protease inhibitors selectively inhibit presentation of antigen incorporated through B cell antigen receptors.
    Togashi K; Magae J; Kataoka T; Nagai K
    Biochem Biophys Res Commun; 1995 May; 210(2):324-8. PubMed ID: 7755606
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CD19-CD21 complex regulates an intrinsic Src family kinase amplification loop that links innate immunity with B-lymphocyte intracellular calcium responses.
    Tedder TF; Haas KM; Poe JC
    Biochem Soc Trans; 2002 Aug; 30(4):807-11. PubMed ID: 12196203
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Germinal centers still hold secrets.
    MacLennan IC
    Immunity; 2005 Jun; 22(6):656-7. PubMed ID: 15963779
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.
    van Zelm MC; Smet J; Adams B; Mascart F; Schandené L; Janssen F; Ferster A; Kuo CC; Levy S; van Dongen JJ; van der Burg M
    J Clin Invest; 2010 Apr; 120(4):1265-74. PubMed ID: 20237408
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transmembrane signaling in T lymphocyte dependent B lymphocyte activation.
    Cambier JC
    Semin Immunol; 1989 Sep; 1(1):43-54. PubMed ID: 15630958
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement.
    Inabe K; Kurosaki T
    Blood; 2002 Jan; 99(2):584-9. PubMed ID: 11781242
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Humoral autoimmunity in mice overexpressing B cell surface CD19: vital role for MHC class II.
    Stohl W; Xu D; Kim KS; Tedder TF; Sato S
    Clin Immunol; 2005 Sep; 116(3):257-64. PubMed ID: 15963762
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyclosporine facilitates B-cell membrane immunoglobulin capping.
    Mosbach-Ozmen L; Humez S; Koponen M; Fonteneau P; Loor F
    Immunology; 1986 Apr; 57(4):573-7. PubMed ID: 3485570
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
    Fearon DT
    Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972
    [No Abstract]   [Full Text] [Related]  

  • 79. CD86 regulates IgG1 production via a CD19-dependent mechanism.
    Kin NW; Sanders VM
    J Immunol; 2007 Aug; 179(3):1516-23. PubMed ID: 17641017
    [TBL] [Abstract][Full Text] [Related]  

  • 80. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
    Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.